Osisko Metals Announces C$15 Million “Bought Deal” Flow-Through Share Financing GlobeNewswire January 12, 2026 NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Jan. 12, 2026 (GLOBE NEWSWIRE) — Osisko Metals Incorporated (the “Company” or “Osisko Metals“) (TSX: OM; OTCQX: OMZNF; FRANKFURT: OB51) is pleased to announce […]
WindRose Health Investors, LLC (“WindRose”), the New York-based healthcare private equity firm, announced that it has completed an investment in Avalon Healthcare Solutions (“Avalon” or the “Company”), a platform that integrates laboratory science and data to power real-time, lab-driven insights on behalf of health plan clients. Francisco Partners, a leading global investment firm that specializes
Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as “Lynk Pharmaceuticals”), a clinical stage innovative drug development company focused on developing innovative therapies for immune and inflammatory diseases, today announced positive topline results from its Phase III clinical trial evaluating zemprocitinib (LNK01001) in patients with moderate to severe active rheumatoid arthritis (RA). The study met its
NextPower Capital Announces Rebrand to Accredant Capital Accredant Capital is pleased to announce it has advised Segue Sustainable Infrastructure (“Segue”) on the sale of a development-complete community solar portfolio in Illinois to Radial Power. The projects, developed by Carson Power, a development partner of Segue, are positioned to deliver clean energy to communities across Illinois.
HSK39004, a novel dual?target therapy, aims to compete in the global COPD market, highlighting innovation and international capabilities On January 9, 2026, Haisco Pharmaceutical Group Co., Ltd. (Ticker Code: 002653) announced that it has entered into an exclusive licensing agreement with US based biotech AirNexis. Under the agreement, Haisco grants AirNexis the rights to develop,
Acquisition to expand urology offerings for people living with overactive bladder Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire Valencia Technologies Corporation, a privately held medical technology company focused on the development and commercialization of innovative solutions to treat bladder dysfunction. The company's eCoin® System is an
(NYSE MKT:CATX), Continued strong patient recruitment in neuroendocrine tumors for lead program VMT-α-NET sets the stage for submissions of robust clinical data package for presentation to more medical conferences in 2026, as well as regulatory engagement VMT-α-NET continues to be well-tolerated and shows durable disease control and deepening of tumor response with longer follow-up as
DUBAI, United Arab Emirates, Jan. 12, 2026 (GLOBE NEWSWIRE) — In every cycle, there are periods when quiet development begins turning into visible progress. That moment often happens when a new protocol enters its operational roadmap and begins releasing information that signals it is ready to transition from planning into deployment. In the DeFi sector,
(NasdaqGM:KWM), NEW YORK, Jan. 12, 2026 (GLOBE NEWSWIRE) — K Wave Media Ltd. (Nasdaq: KWM), a global entertainment and media company, is extending its track record of successful K content investments. Building on the global success of its Netflix original series Trigger, the company now reports that Once We Were Us, a feature film released
(TSX-V:STUD),(Boerse Frankfurt – Freiverkehr:HM40.F),(OTC US:STLNF),(Other OTC:STLNF),(Frankfurt:FE0),(Boerse Frankfurt – Freiverkehr:B76), VANCOUVER, British Columbia, Jan. 12, 2026 (GLOBE NEWSWIRE) — Stallion Uranium Corp. (the “Company” or “Stallion“) (TSX-V: STUD; OTCQB: STLNF; FSE: B76) is pleased to announce the completion of a ground-based Step-Wise Moving Loop (“SWML”) Time-Domain Electromagnetic (TDEM) survey at the Coyote Target on its Moonlite